2023 - Non-Invasive Approaches to NAFLD/NASH Drug Development
Date2023-06-27
Deadline2023-06-27
VenueWebinar, USA - United States
KeywordsDrug Development; Liver Disease; NASH
Topics/Call fo Papers
This webinar will focus on non-invasive approaches to NAFLD/NASH drug development. During the webinar, speakers will provide updates on current and emerging NASH biomarkers, which are also anticipated to be important tools in clinical practice. The audience will learn how data generated from these biomarker tests can inform clinicians, identify treatment efficacy and lead to identification of new biomarker targets.
Join this informative webinar on non-invasive strategies for NAFLD/NASH drug development. Gain valuable knowledge about the latest NASH biomarkers and their practical applications in clinical settings.
Join this informative webinar on non-invasive strategies for NAFLD/NASH drug development. Gain valuable knowledge about the latest NASH biomarkers and their practical applications in clinical settings.
Other CFPs
- Producing High Quality CRISPR-Cas9 Edited hiPSCs for Cardiac Disease Modeling
- Optimizing Clinical Trial Supply Chain with End-to-End Condition Monitoring: A Case Study
- Navigating IVDR: Challenges and Strategies for Clinical Trial Assay Development and Regulatory Submissions
- Accelerating TB Vaccine Development: Insights from Microsampling, Biomarkers and Data Analysis
- Demystifying Goal Attainment Scaling: Personalized Endpoints in FDA Patient-Focused Drug Development
Last modified: 2023-06-22 01:25:20